Atom | CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)

Due Dates: April 30, 2025 (Letter of Intent) | May 30, 2025 (Full Application, Renewal/Resubmission/Revision)

Funding Amounts: Up to $275,000 in direct costs over 2 years; no more than $200,000 in any single year.

Summary: Supports translational exploratory/developmental research to advance novel medical countermeasures for acute exposure to highly toxic chemical threats.

Key Information: Clinical trials are not allowed; projects must focus on preclinical development of treatments for acute, not chronic, chemical exposures.

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)

Sign in to see full grant listing